188 related articles for article (PubMed ID: 23276939)
1. TGM2 and implications for human disease: role of alternative splicing.
Lai TS; Greenberg CS
Front Biosci (Landmark Ed); 2013 Jan; 18(2):504-19. PubMed ID: 23276939
[TBL] [Abstract][Full Text] [Related]
2. Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.
Thangaraju K; Király R; Demény MA; András Mótyán J; Fuxreiter M; Fésüs L
PLoS One; 2017; 12(3):e0172189. PubMed ID: 28248968
[TBL] [Abstract][Full Text] [Related]
3. Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.
Lai TS; Liu Y; Li W; Greenberg CS
FASEB J; 2007 Dec; 21(14):4131-43. PubMed ID: 17609251
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.
Zhang S; Yao HF; Li H; Su T; Jiang SH; Wang H; Zhang ZG; Dong FY; Yang Q; Yang XM
Cell Oncol (Dordr); 2023 Oct; 46(5):1473-1492. PubMed ID: 37246171
[TBL] [Abstract][Full Text] [Related]
5. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors.
Eligini S; Fiorelli S; Tremoli E; Colli S
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):922-30. PubMed ID: 27378395
[TBL] [Abstract][Full Text] [Related]
7. Cellular functions of tissue transglutaminase.
Nurminskaya MV; Belkin AM
Int Rev Cell Mol Biol; 2012; 294():1-97. PubMed ID: 22364871
[TBL] [Abstract][Full Text] [Related]
8. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries.
Lai TS; Liu Y; Tucker T; Daniel KR; Sane DC; Toone E; Burke JR; Strittmatter WJ; Greenberg CS
Chem Biol; 2008 Sep; 15(9):969-78. PubMed ID: 18804034
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
Lai TS; Lin CJ; Wu YT; Wu CJ
Front Biosci (Landmark Ed); 2017 Mar; 22(7):1114-1137. PubMed ID: 28199195
[TBL] [Abstract][Full Text] [Related]
10. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
Hitomi K; Ikura K; Maki M
Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
[TBL] [Abstract][Full Text] [Related]
11. Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation.
Lai TS; Davies C; Greenberg CS
Protein Sci; 2010 Feb; 19(2):229-35. PubMed ID: 19998405
[TBL] [Abstract][Full Text] [Related]
12. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration.
Citron BA; Suo Z; SantaCruz K; Davies PJ; Qin F; Festoff BW
Neurochem Int; 2002 Jan; 40(1):69-78. PubMed ID: 11738473
[TBL] [Abstract][Full Text] [Related]
13. Study of tissue transglutaminase spliced variants expressed in THP-1 derived macrophages exhibiting distinct functional phenotypes.
Arbildi P; Calvo F; Macías V; Rodríguez-Camejo C; Sóñora C; Hernández A
Immunobiology; 2023 Nov; 228(6):152752. PubMed ID: 37813017
[TBL] [Abstract][Full Text] [Related]
14. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.
Lai TS; Hausladen A; Slaughter TF; Eu JP; Stamler JS; Greenberg CS
Biochemistry; 2001 Apr; 40(16):4904-10. PubMed ID: 11305905
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
16. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
[TBL] [Abstract][Full Text] [Related]
17. Organization and chromosomal mapping of mouse Gh/tissue transglutaminase gene (Tgm2).
Nanda N; Iismaa SE; Copeland NG; Gilbert DJ; Jenkins N; Graham RM; Sutrave P
Arch Biochem Biophys; 1999 Jun; 366(1):151-6. PubMed ID: 10334875
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.
Yamaguchi H; Kuroda K; Sugitani M; Takayama T; Hasegawa K; Esumi M
Int J Oncol; 2017 May; 50(5):1749-1759. PubMed ID: 28339069
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 5 is regulated by guanine-adenine nucleotides.
Candi E; Paradisi A; Terrinoni A; Pietroni V; Oddi S; Cadot B; Jogini V; Meiyappan M; Clardy J; Finazzi-Agro A; Melino G
Biochem J; 2004 Jul; 381(Pt 1):313-9. PubMed ID: 15038793
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target.
Malkomes P; Lunger I; Oppermann E; Lorenz J; Faqar-Uz-Zaman SF; Han J; Bothur S; Ziegler P; Bankov K; Wild P; Bechstein WO; Rieger MA
Cancer Gene Ther; 2023 Oct; 30(10):1346-1354. PubMed ID: 37443286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
